Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Commencement of Two Pivotal BIT225 Clinical Trials

1 November 2021 by Audrey Thomson

Commencement of Two Pivotal BIT225 Clinical Trials

Categories 2021, ASX Announcements
Report on Activities for the Quarter ended 30 September 2021
Presentation to Annual General Meeting
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 6 June 2025        Legal Notices and Privacy
Cleantalk Pixel